Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses

BACKGROUND: Thymomas and thymic carcinoma are rare tumors with no approved therapies. Our purpose was to analyze the molecular features and outcomes of patients referred to the Clinical Center for Targeted Therapy (Phase I Clinic). METHODS: We retrospectively reviewed the medical records of consecut...

Full description

Saved in:
Bibliographic Details
Main Authors: Wheler, Jennifer, Hong, David, Swisher, Stephen G., Falchook, Gerald, Tsimberidou, Apostolia M., Helgason, Thorunn, Naing, Aung, Stephen, Bettzy, Janku, Filip, Stephens, Philip J., Yelensky, Roman, Kurzrock, Razelle
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2013
Subjects:
Research Papers
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3757246/
https://ncbi.nlm.nih.gov/pubmed/23765114
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items